Table 2.
ALL population | Pilot cohort* | Validation cohort† | P (χ2 test) |
---|---|---|---|
Total number | 465 of 552 | 339 of 347 | .001 |
Score 2.5 or lower, n (%) | 394 (86.4) | 322 (94.9) | |
Score greater than 2.5, n (%) | 62 (13.5) | 17 (5.01) | |
VTE onset, d, n (%) | 34 (7.5) | 19 (5.9) | .41 |
Median (min-max) | 32 (12-39) | 34 (13-49) | |
Score 2.5 or lower, n (%) | 11 (2.8) | 8 (2.5) | |
Score greater than 2.5, n (%) | 23 (37) | 11 (64.7) | <.001‡ |
ALL indicates acute lymphoblastic leukemia; and VTE, venous thromboembolism.
Included BFM 90/95 and COALL 92/97.
Included BFM 2000 and FRALLE 2000.
P value for score < 2.5 vs > 2.5.